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ABSTRACT 
Rationale, aims and objectives: Widely-used in the evaluation of non-randomized interventions, 
propensity scores estimate the probability that an individual will be assigned to the treatment 
group given the observed characteristics.  Machine learning algorithms have been proposed as an 
alternative to conventional logistic regression-based modelling of propensity scores in order to 
avoid many limitations of linear methods. In this paper we introduce the use of classification tree 
analysis (CTA) to generate propensity scores. CTA is a “decision-tree”-like classification model 
that provides accurate, parsimonious decision rules that are easy to visually display and interpret, 
reports P values derived via permutation tests performed at each node, and evaluates potential 
model cross-generalizability.  
Method: Using empirical data, we identify all statistically valid CTA propensity score models 
and then use them to compute strata-specific, observation-level propensity score weights that are 
subsequently applied in outcomes analyses. We compare findings obtained using this framework 
to the conventional method (logistic regression) and a popular alternative machine learning 
approach (boosted regression), by evaluating covariate balance using standardized differences, 
model predictive accuracy, and treatment effect estimates obtained using median regression and 
a weighted CTA outcomes model. 
Results: While all models had some imbalanced covariates, main-effects logistic regression 
yielded the lowest average standardized difference, whereas CTA yielded the greatest predictive 
accuracy. Nevertheless, treatment effect estimates were generally consistent across all models.  
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Conclusions: Assessing standardized differences in means as a test of covariate balance is 
inappropriate for machine learning algorithms that segment the sample into two or more strata. 
Because the CTA algorithm identifies all statistically valid propensity score models for a sample, 
it is most likely to identify a correctly specified propensity score model, and should be 
considered as an alternative approach to modeling the propensity score.  
This article is protected by copyright. All rights reserved.
1. INTRODUCTION 
Introduced in 1983, the propensity score joined other widely-used methods (e.g. instrumental 
variables [1,2]) that explicitly model treatment assignment in order to estimate treatment effects 
in non-randomized studies. The propensity score is defined as the probability of assignment to 
the treatment group given the observed characteristics [3]. It has been demonstrated that, in 
sufficiently large samples, if treatment and control groups have similar distributions of the 
propensity score they generally have similar distributions of the covariates used to create the 
propensity score (i.e., they exhibit covariate balance). The observed baseline covariates can thus 
be considered independent of treatment assignment (as if they were randomized), and therefore 
will not bias treatment effect estimates [3]. 
 Currently there is no consensus regarding how best to estimate the propensity score. In a 
survey of the literature, Weitzen et al. [4] reported that propensity score estimation is nearly 
universally performed via logistic regression, and that there is tremendous inconsistency in how 
models are estimated. For example, some investigators estimate models in which the variable 
selection process includes only main effects, while others estimate completely saturated models 
(including all possible interactions, and squared and cubed terms), while others use automated 
forward or backward stepwise procedures to select variables for model inclusion.  
 The fundamental concern with this heterogeneous approach to propensity score 
estimation is that the resulting propensity score model is likely to be misspecified -- that is, the 
estimated probability of being in the treatment group may differ substantially from the 
corresponding true probability [5]. With increasing degrees of misspecification it may become 
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implausible to assume that the propensity score accurately represents the underlying covariate 
distributions, but rather that individuals are not conditionally exchangeable between study 
groups. In short, a misspecified propensity score may fail to achieve covariate balance between 
treatment groups, which will subsequently bias treatment effect estimates -- the greater the 
imbalance, the stronger the bias [6,7]. 
 To avoid the limitations of conventional statistical methods, several investigators have 
suggested the use of machine learning algorithms as an alternate approach for estimating the 
propensity score [8-15]. Machine learning algorithms find the best fitting model through 
automated processes that search through the data to detect patterns that may include interactions 
between variables, as well as interactions within subsets of variables. This is in contrast to 
conventional statistics, where a model is chosen and estimated based on an a priori hypothesis 
about the relationship between the variables, and then statistical tests are performed to evaluate 
whether the data fit crucial assumptions underlying the validity of the findings [16]. In short, 
machine learning allows the data to dictate the form of the model, whereas conventional statistics 
attempts to fit the data to an investigator-specified model.  
 While there are hundreds of machine learning classification algorithms to choose from 
[17], the models most often examined in the propensity score literature are classification and 
regression trees (CART) [8,9,11,12], neural networks [11], and ensemble methods such as 
boosted regression [10,12,14] and random forests [12]. Studies that have conducted head-to-head 
comparisons between machine learning algorithms and logistic regression for estimating the 
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propensity score have generally found that machine-learning models outperform logistic 
regression in terms of reduced bias (i.e. the difference between the estimated effect versus the 
true effect) in the outcome [10-12]. 
 In this paper, we introduce classification tree analysis (CTA) [18,19] and assess whether 
it offers a superior alternative to logistic regression and boosted regression for estimating 
propensity scores. CTA is a “decision-tree”-like classification model that provides accurate, 
parsimonious decision rules that are easy to visually display and interpret, while reporting P 
values derived via permutation tests performed at each node -- making this approach particularly 
attractive to investigators coming from statistics-based disciplines as compared to other machine 
learning approaches. In our proposed approach, once a CTA model is generated, strata-specific 
propensity score weights are computed for all observations in the sample. These weights are then 
applied in the subsequent outcomes analysis. We illustrate the implementation of the CTA-
weighting framework and compare it to weighting approaches using propensity scores derived 
from conventional logistic regression as well as from boosted logistic regression that is presently 
the most popular machine learning approach for estimating the propensity score [10].  
 The paper is organized as follows. In the Methods section we provide a brief introduction 
to CTA, and describe the data source and analytic framework employed in the current study. The 
Results section reports and compares the results of the logistic regression, boosted regression and 
CTA-weighting framework. The Discussion section describes the specific advantages of the 
CTA-weighting framework for estimating the propensity score and evaluating treatment effects 
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compared with logistic regression and other machine learning approaches, and discusses how 
CTA can be applied more broadly within the causal inferential framework. 
2. METHODS 
2.1 A brief introduction to Classification Tree Analysis 
In its simplest form, CTA is an optimal discriminant analysis (ODA) model [20]. ODA is a 
machine-learning algorithm that finds the cutpoint(s) on an ordered attribute (variable) that 
maximally discriminates between two or more classes (e.g. treatment groups) [21]. The optimal 
cutpoint is determined by iterating through each value on the attribute and calculating the effect 
strength for sensitivity [ESS], which is the mean sensitivity amongst the classes, standardized to 
a 0 - 100% scale where 0 represents the discriminatory accuracy expected by chance, and 100% 
represents perfect discrimination. By definition, the maximally accurate predictive model uses 
the “optimal” cutpoint achieving the highest ESS. This model is further subjected to a non-
parametric permutation test to assess the statistical validity of that cutpoint. Finally, 
reproducibility and generalizability of the model are assessed using cross-validation methods 
[18,22,23]. 
 CTA models use one or more attributes to classify a sample of observations into two or 
more subgroups that are represented as model endpoints (these are called “terminal nodes” in 
alternative decision-tree methods). Subgroups are known as “sample strata” because the CTA 
model stratifies the sample into subgroups of observations that -- with respect to model attributes 
-- are homogeneous within and heterogeneous between strata [18]. The initial “hierarchically-
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optimal” CTA algorithm involves chained ODA models in which the initial (“root”) node 
represents the attribute achieving the highest ESS value for the entire sample, and additional 
nodes yielding greatest ESS are iteratively added at every step on all model branches [24]. In 
contrast, the enumerated-optimal CTA algorithm explicitly evaluates all possible combinations 
of the first three nodes, which dominate the solution [25]. The most robust globally-optimal 
(GO) CTA algorithm explicitly evaluates all possible solutions (called the descendant family), 
and identifies the model reflecting the best combination of ESS and parsimony (i.e. the model 
yielding highest ESS using the fewest strata). The software that implements ODA and CTA 
models provides users with a vast array of options for controlling the modeling process, and a 
comprehensive description can be found elsewhere [18]. 
2.2 Data 
We use data from a primary care-based medical home pilot program that invited patients to 
enroll if they had a chronic illness or were predicted to have high costs in the following year 
[26]. The goal of the program was to lower healthcare costs for program participants by 
providing intensified primary care [27]. The retrospectively collected data consist of 
observations for 374 program participants and 1,628 non-participants. Eleven pre-intervention 
characteristics were available; these included demographic variables (age and gender), health 
services utilization (primary care visits, other outpatient visits, laboratory tests, radiology tests, 
prescriptions filled, hospitalizations, emergency department visits, and home-health visits), and 
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total medical costs. The outcome was total medical costs in the program year (see [26] for a more 
comprehensive description). 
2.3 Estimating the propensity score 
This study compared three different modelling approaches for estimating propensity scores. 
Fundamental characteristics of each approach are described in this section, and corresponding 
methods for computing propensity scores are described in the next section. 
  The first approach, which is the most commonly used in practice, involves estimating a 
logistic regression model to predict program participation status using the eleven pre-
intervention covariates described above, all entered as main effects. We also estimate a fully 
saturated logistic regression model which includes the eleven main effects, all possible 
interactions (including squared terms), and cubed terms for continuous variables. The fully 
saturated model represents the extreme use of logistic regression for estimating the propensity 
score, in which every possible relationship between the covariates and outcome (treatment 
assignment) is explored. 
 The second approach uses a popular machine learning algorithm called boosted logistic 
regression for estimating the propensity score [10]. Boosted regression is a procedure in a family 
of machine learning classifiers called ensemble methods, which combines a large number of 
relatively simple models (e.g. decision trees) adaptively to optimize predictive performance. 
Boosting follows a sequential process in which decision trees are fitted iteratively to random 
subsets of the data, gradually increasing emphasis on observations modelled poorly by the 
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existing collection of trees. The final boosted model is a linear combination of many trees 
(usually hundreds to thousands) that can be thought of as a regression model where each term is 
a tree [28]. Here we apply the boosted approach to estimating propensity scores as described by 
McCaffrey et al [2004], and we implement it in Stata using the user-written program BOOST 
[29], setting the maximum iterations at 20,000, the shrinkage factor to 0.0005, the percentage of 
data to be used as training data at 80%, the fraction of training observations to be used to fit an 
individual tree at 50%, and allow up to seven interactions to be assessed. All eleven pre-
intervention covariates were used to predict program participation. 
 The third approach uses the GO-CTA algorithm [18]. For any given dataset, multiple 
propensity score models having 90% power to test a non-directional hypothesis with 
experimentwise P <0.05 may be generated depending on the subset of covariates and interactions 
included. We utilize the GO-CTA approach to identify and select the optimal model in the family 
of all statistically valid CTA models that exist for the sample, evaluating all eleven pre-
intervention covariates for inclusion. Point estimates and exact discrete 95% confidence intervals 
(CIs) are computed for ESS and D (ESS normed for parsimony) for every model in the family, 
for model performance as well as for chance: if model and chance 95% CIs overlap then the 
model is judged to be statistically invalid. The GO model is defined as the CTA model within the 
family of models which has the smallest D statistic. Generalizability of model performance is 
estimated presently using leave-one-out (LOO) cross-validation. We constrained all CTA models 
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to yield identical predictive accuracy in training and LOO analysis [18,30]. Once all the CTA 
models were generated, weights were computed for individuals in all end-point strata.   
2.4 Generating propensity score weights 
Reflecting conventional practice, the inverse probability of treatment weight (IPTW) was 
computed for each individual in the sample [31]. The IPTW is based on the conditional 
probability of an individual receiving his/her own treatment: IPTWi = (Zi / pi) + ([1 − Zi] / [1 − 
pi]). In this approach an individual i in the treatment group (Z = 1) receives a weight equal to the 
inverse of the estimated propensity score p, and an individual in the control group (Z = 0) 
receives a weight equal to the inverse of 1 minus p. The IPTW weights the treated and control 
groups to reflect the characteristics of the combined sample in order to estimate the average 
treatment effect [32,33]. 
 In contrast, for CTA models a stratified weight is generated for each individual based on 
both their actual treatment assignment and their specific stratum (model endpoint): observations 
have identical weights if they are classified into the same endpoint and they have the same actual 
treatment assignment (i.e. treated or non-treated). CTA model-based stratified weights are 
computed using the following formula: 
𝑛𝑠 × Pr (𝑍 = 𝑧) 
𝑛𝑧 = 𝑧,𝑠           (1) 
where 𝑛𝑠 is the total number of individuals in a given stratum 𝑠, Pr (𝑍 = 𝑧) is the estimated 
probability of assignment to treatment group 𝑧 (i.e., the proportion of individuals actually 
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receiving treatment 𝑧 in the sample), and 𝑛𝑧 = 𝑧,𝑠 is the total number of individuals in stratum 𝑠 
who were actually assigned to treatment 𝑧. Thus, the weight is proportional to the ratio of the 
number of individuals in a given stratum relative to the number of individuals within that stratum 
who do (not) receive treatment. Taken together, the stratification reduces bias in the observed 
covariates used to create the propensity score, and the weighting standardizes each treatment 
group to the target population. We developed this stratified weighting approach for the CTA 
models to ensure that weights conform exactly to the underlying geometry and findings of the 
CTA model. Although stratified weighting has been shown to produce less bias than IPTW when 
the propensity score is misspecified [34], we apply IPTW in the comparison models to be 
consistent with other (prior) studies using machine learning for generating propensity score 
weights [12].  
2.5 Estimating treatment effects 
For all propensity score weighted models, we estimated treatment effects using two approaches. 
In the first approach we estimate treatment effects using quantile (median) regression, in which 
the outcome variable (medical costs in the program year) is regressed on the treatment indicator, 
the weights specified as sampling weights, and standard errors and confidence intervals 
computed via a bootstrap procedure with 2,000 repetitions [35]. Quantile regression is used 
because medical costs are highly skewed and contain several outliers.  
 In the second approach, we estimate treatment effects using another CTA model (other 
than the initial model that generated the propensity scores). Here, medical costs are specified as 
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the attribute, treatment assignment is specified as the class variable, and the weights are used for 
adjustment. Exact P values were estimated using 25,000 Monte Carlo experiments, and LOO 
analysis (single-case jackknife analysis) was performed to assess potential cross-generalizability 
of the model in correctly classifying individuals outside of the sample used for model estimation 
[23,36]. 
2.6 Performance metrics 
We use several methods for assessing the performance across the propensity score estimation 
models. First, we use the absolute standardized difference statistic for assessing whether 
weighting on the propensity score successfully balanced the covariates [37]: 
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where the numerator is the absolute difference in means between the treatment and control 
groups (denoted as T and C, respectively) and the denominator is a 50:50 pooled standard 
deviation [38]. While there is currently no universally-recognized cut-off point as to what is 
considered the upper limit of balance, Normand et al. [39] suggest that a standardized difference 
of less than 0.10 is indicative of good balance. 
We use ESS to assess the accuracy of fit amongst the various outcome models. The ESS 
statistic is a chance-corrected (0 = the level of accuracy expected by chance) and maximum-
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corrected (100 = perfect prediction) index of predictive accuracy. The formula for computing 
ESS for binary case classification is [40]: 
     ESS = [(Mean Percent Accuracy in Classification –50)]/ 50 x 100%    (3),  
where  
     Mean Percent Accuracy in Classification = (sensitivity + specificity)/2 x 100   (4).   
Based on simulation studies, Yarnold and Soltysik [40] consider ESS values less than 
25% to indicate a relatively weak, 25% to 50% to indicate a moderate, 50% to 75% to indicate a 
relatively strong, and 75% or greater to indicate a strong effect. Using ESS, an investigator may 
directly compare the performance among the various propensity score and outcome models, 
regardless of structural features of the analyses, such as sample size and the measurement metric. 
While ESS compares the predictive accuracy of every given model versus chance, 
different models may achieve the same level of normed accuracy using different numbers of 
sample strata. Because model complexity increases as the number of sample strata increases, the 
D (for “distance”) statistic standardizes model ESS for parsimony. The formula for computing D 
for binary case classification is [18]: 
     D = 100/(ESS/2)-2           (5),  
where the resulting value gives the number of additional effects of identical strength (i.e., ESS) 
observed for the model that are needed to obtain a theoretically ideal model having perfect 
accuracy using the minimum number of strata possible for the sample: if accuracy is perfect then 
D = 0 [41]. 
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  Finally, we assess the generalizability (external validity) of the models using LOO cross-
validation. We conduct these analyses to assess how well the model predicts treatment 
assignment to new study participants who may have somewhat different characteristics than 
those in the original sample. The ESS of the cross-validated model is compared to those of the 
original model using the entire data-set. The model is considered generalizable if the accuracy 
measures remain consistent with those of the original model. Current practice guidelines 
recommend constraining CTA models to have identical ESS in training (total sample) and LOO 
analysis as a means of inhibiting overfitting and maximizing cross-generalizability [18,42]. 
2.6 Analytic software 
Stata 14.1 (StataCorp., College Station, TX, USA) was used to perform logistic regression and 
boosted logistic regression for estimating the propensity score and quantile regression for 
estimating treatment effects (outcome model). We estimated the two logistic regression models 
(main effects only, and fully saturated) using a user-written command for Stata, LOOCLASS [43], 
which performs LOO and produces several classification measures. We estimated a boosted 
logistic regression implementing the user-written program BOOST [29], within a modified 
wrapper program of LOOCLASS to provide the LOO estimates for the boosted model. 
Standardized differences were computed using a user-written command for Stata, COVBAL [44]. 
GO-CTA was conducted to generate and assess the accuracy of propensity score models, and to 
model outcomes, and was performed using CTA software [18,25].  
3. RESULTS 
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Table 1 presents the observed pre-intervention characteristics of the participants and non-
participants in the pilot study [26]. Continuous variables are summarized by the mean and 
standard deviation, and categorical variables are presented as number and percent. For balance 
measures, we report the standardized difference, for which perfect balance is zero and the 
conventional P value, where variables with values ≤ 0.05 may be considered imbalanced. It is 
clear that the participant group differed markedly from the non-participant group on every 
characteristic. On average, participants were older, were less likely to be female, and had higher 
utilization and costs than non-participants. All standardized differences exceeded the 
recommended value of 0.10, and all P values were ≤ 0.05. Thus, it is readily apparent that this 
non-randomized study exhibits substantial selection bias. 
 Table 2 summarizes the structure (number of strata, smallest strata N) and performance 
(ESS, D) of all CTA models that emerged for discriminating between study participants and non-
participants. Disqualified models either failed to achieve the minimum denominator criterion 
(N>34) specified in power analysis (steps 1-4), or had 95% CIs for D (steps 13-14) lower than 
for the globally-optimal model in the family (step 12). The descendant family (DF) thus 
consisted of the eight models in steps 5-12: note that all eight models had ESS 95% CIs that 
overlapped and reflected relatively strong normed predictive accuracy, and all eight models had 
chance ESS 95% CIs that overlapped and reflected relatively weak normed predictive accuracy. 
However, model 12 is unambiguously identified as the GO model since its 95% CI for D lay 
below corresponding 95% CIs for all other models in the DF [18,41].  
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Although all eight models in the DF may be used to construct propensity scores, for this 
exposition we limit our analysis to the four models illustrated in Appendix Figures 1-4, 
respectively. Results are reported for the least complex two-strata GO model [CTA-2] (Table 2, 
step 12); the most accurate (highest ESS) next-least complex four-strata model [CTA-4] (step 9); 
the sole intermediate-complexity six-strata model [CTA-6] (step 8); and the nine-strata model 
[CTA-9] -- the first and most complex member of the DF, offering greatest stratification 
granularity (step 5). All of these models had overlapping 95% CIs for ESS, and all correctly 
classified at least 3 of 4 non-participants, and 4 of 5 program participants. 
 Table 3 presents standardized differences of all covariates and the average absolute 
standardized difference for each of the seven (logistic-main effects, logistic-saturated, boosted, 
and four CTA) weighted propensity score models. The main effects only logistic regression 
model with IPTW achieves the lowest average standardized difference amongst the models, but 
is far from ideal in achieving covariate balance. For example, age remains substantially 
unbalanced between participants and non-participants, and to a lesser degree so do the number of 
prescriptions filled, emergency department visits, and other outpatient visits. Interestingly, the 
saturated logistic regression model performed worse in achieving covariate balance than the 
main effects only model. This may be due to the very large number of covariates used in the 
estimation model (166) relative to the number of observations (2002), resulting in data patterns 
known as complete or quasi-complete separation [45]. All other models performed substantially 
worse than logistic regression with IPTW in achieving covariate balance.  
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 Table 4 presents treatment effect estimates using median regression for the seven 
weighted propensity score models and also for a naïve estimate, which is simply a regression of 
the outcome on the treatment indicator without adjustment for confounding. All models show 
that the median costs of the participants in the program year were higher than the median costs of 
non-participants. The treatment effect estimates for the seven weighted models span a relatively 
narrow range between $738 and $1536, and all models except for the saturated logistic model (P 
<0.094) achieve statistical significance (P <0.0001). 
 Table 5 presents treatment effect estimates using weighted CTA outcome models for the 
seven weighted propensity score models and also for the naïve estimate. For every analysis, the 
first row of data are for the training (full sample) analysis, and the second row for leave-one-out 
(LOO) one-sample jackknife analysis. For all models, observations having costs less than or 
equal to the tabled threshold value (each threshold value is computed using the indicated model) 
are predicted to be from the non-participant group, and observations having costs that are greater 
than the tabled threshold are predicted to be from the participant group.  
For example, the cutpoint in the unweighted naïve model indicates that non-participants 
were predicted to have medical costs ≤ $2664 while participants were predicted to have costs > 
$2664. The accuracy (and LOO cross-generalizability) of these predictions is represented by the 
respective sensitivities, overall ESS, and permutation P values. In the case of the naïve estimate, 
the full sample sensitivity of the non-participant group was 68.2%, indicating that 68.2% of non-
participants we accurately predicted to have costs ≤ $2664. Similarly, the full sample sensitivity 
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of the participant group was 82.6%, indicating that 82.6% of participants were accurately 
predicted to have costs > $2664. The ESS for the naïve model was 50.8%, indicative of relatively 
strong overall classification accuracy [40]. Furthermore, the exact P<0.0001 for the naïve model 
indicates that the participant group had statistically higher cost than then non-participant group. 
Finally, the model is generalizable, as indicated by LOO values that are nearly identical to those 
of the full sample.  
All weighted models were statistically significant (exact P<0.0001). Full sample 
weighted ESS (WESS) values ranged between 28.5% and 37.3%, and LOO WESS values ranged 
between 26.3% and 36.6%, indicative of moderate classification accuracy and cross-
generalizability [40]. Taken together the findings of the CTA outcomes analyses were 
qualitatively similar to findings derived via median regression. That is, the participant group had 
statistically higher costs than the non-participant group, across all models. We close with 
concluding comments. 
4. DISCUSSION 
Given that main-effects logistic regression generated propensity scores weights that yielded the 
lowest mean standardized difference measure of covariate balance, and produced median-
regression-based treatment effect estimates that were consistent with estimates of all the other 
models, one may question the value of using alternative approaches to generate propensity 
scores. However, in using empirical data where the true treatment effect is never known, we 
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highlight challenges investigators face when developing propensity score models using logistic 
regression to derive the best (i.e. least biased) estimate.  
 First, neither the main effects nor the fully saturated logistic regression models generated 
propensity scores that yielded good covariate balance, indicated by standardized differences for 
several covariates that were substantially higher than the recommended upper bound of 0.10 
[39]. If in fact it is possible to attain a correctly specified logistic regression model for the 
present sample, then it lies somewhere between these extreme (main effects only, versus 
completely saturated) specifications. However, a correctly specified logistic regression model is 
unlikely to be discovered by using a manual variable selection approach.  
 Second, as an increasing number of variables, interactions, and polynomial terms are 
added to the model, violations of statistical assumptions underlying the validity of the model 
estimates become increasingly likely. This underscores a clear advantage of using automated 
machine learning algorithms, which require no statistical assumptions in selecting model terms, 
as an alternative to logistic regression for generating propensity scores. 
 Third, as expected, varying the specifications for estimating the logistic regression model 
yielded qualitatively different findings. The main effects logistic regression model produced 
estimated treatment effects consistent in magnitude and statistical significance to estimates of all 
weighted models except for the saturated logistic regression model, which produced an estimated 
treatment effect that was substantially lower than that obtained by all other models, and was not 
statistically significant (Table 4). This finding supports conducting sensitivity analysis to assess 
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the consistency of findings obtained by different models (or specifications) as a standard practice 
in the propensity score modeling process, in order to increase confidence in the validity of the 
analytic results [46]. By design, the CTA framework conducts such a sensitivity analysis for the 
propensity score models. In the present study, analysis identified all 14 potential CTA-based 
propensity score models that exist for the study data, of which eight met all statistical validity 
criteria (for exposition we proceeded with four of these eight models). All CTA models produced 
overlapping outcomes, cutpoints, ESS, and P values for all weighted models, and exhibited 
consistency in the degree of generalizability of the estimates. In achieving similar outcomes 
under different propensity score model specifications, we gain confidence that the analytic 
approach produces valid results.  
 Our empirical results also reveal that the standard approach to assess covariate balance as 
an indicator of comparability between study groups is problematic. None of the machine 
learning-based models (nor the saturated or boosted logistic models) achieved covariate balance 
using the criterion of an average standardized difference <0.10. This indicates that the 
standardized difference is not an appropriate metric for assessing comparability between study 
groups when such models are implemented. The standardized difference measures the difference 
in the means of two (assumingly normal) distributions. However, machine learning algorithms 
rarely deal with entire distributions of a variable, but rather subsets -- and interactions between 
subsets -- of available variables. Therefore, metrics based on distributional assumptions of the 
entire variable are not relevant to machine learning models. 
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On the other hand, CTA models by design provide results in a decision-tree-like format 
that allows for direct inspection of balance, with all individuals that end in the same stratum 
(terminal node) comparable on all the attributes that define that terminal node. Concomitantly, 
this format also indicates the degree of overlap between study groups in these covariate patterns. 
More specifically, any terminal node that contains 100% of observations from a single study 
group has no counterfactual and thus causal inferences cannot be made about the effects of the 
intervention on that subset of observations. In such cases, all observations with no counterfactual 
within a given terminal node may be dropped from the analysis, and the CTA model should be 
re-estimated. While this methodology is applicable to CTA and classification and regression 
trees (CART) algorithms that provide results in a decision-tree or decision-rules format, it is not 
clear how best to assess covariate balance when using “black-box” algorithms (e.g. boosted 
regression, random forests, support vector machines, etc.). 
 An important issue associated with the use of machine learning tools for generating 
propensity score models is the choice and number of variables determined by the model. The 
recommended approach for estimating the propensity score is to “be liberal in terms of including 
variables that may be associated with treatment assignment and/or the outcomes” [46]. However, 
classification algorithms are specifically designed to exclude variables that do not contribute to 
predictive accuracy. Indeed, CTA explicitly maximizes ESS so forcing additional variables into a 
CTA model will reduce ESS and/or D. Moreover, many “black-box” machine learning 
algorithms do not report the number or identify of variables included in the model. Taken 
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together, it is clear that recommendations for estimating propensity score models could be 
improved by including the application of machine learning techniques.   
 CTA methodology holds several advantages over conventional logistic regression for 
estimating propensity score models, such as using an automated process for optimizing variable 
selection, being unencumbered by the assumptions required of parametric models, and 
insensitivity to skewed data and outliers [18]. Moreover, the built-in sensitivity analysis for GO-
CTA is more likely to consistently identify a correctly specified propensity score model than 
when using logistic regression. Additionally, while this paper has demonstrated the 
implementation of the CTA framework to generate propensity score weights for pretest-posttest 
studies with a binary treatment, the approach can be extended to any study design that may 
utilize propensity score weights (see for example [48-52]).  
 CTA methodology also carries advantages over other machine learning algorithms for 
estimating propensity score models. In contrast to the more computationally-intensive machine 
learning techniques typically favored for generating propensity scores, CTA models offer 
transparency in the computational approach, interpretable formulae, and straightforward visual 
displays of the final model [53]. Moreover, the GO-CTA algorithm identifies all statistically 
valid propensity score models for a sample, which vary in terms of predictive accuracy (ESS) as 
well as parsimony (number of strata) [18]. As a general rule, a simpler model is always preferred 
over a more complex model, assuming both have the same classification accuracy. Finally, CTA 
includes permutation tests, adjusted for multiple comparisons, to ensure that the final model 
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meets rigorous statistical assumptions, and can use multiple methods to assess potential cross-
generalizability [18]. Thus, one may consider CTA as an “all-in-one” classification algorithm 
that combines the synergies of machine learning and conventional statistics. That is, the machine 
learning component ensures that the final model achieves maximum accuracy (as measured by 
cross-validated ESS), and the permutation tests, performed at each node, ensure that the model’s 
discriminatory ability has met accepted levels of statistical significance. 
 The primary limitation of the CTA framework -- as is the case with every approach used 
to evaluate non-randomized studies -- is the models are generated using only the available data. 
No matter how sophisticated the algorithm, unobservable factors such as unmeasured motivation 
to change health behaviors may confound the outcomes in healthcare interventions [54,55]. 
5. CONCLUSION 
In summary, this paper introduced a novel machine learning framework for generating 
propensity score weights to evaluate treatment effects in observational studies. This framework 
offers many advantages over both logistic regression as well as other machine learning 
algorithms, such as explicit maximization of accuracy, parsimony, sensitivity, statistical 
robustness, and transparency. Because the CTA algorithm identifies all statistically valid 
propensity score models for a sample, it is most likely to identify a correctly specified propensity 
score model, and should be considered as an alternative approach to modeling the propensity 
score. 
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Table 1: Baseline (12 months) characteristics of program participants and non-participants (Linden [2011]).  
 
  Participants (N=374)   
Non-Participants 
(N=1628)  
Standardized 
difference   P-valuea 
Demographic characteristics        
Age 54.9 (6.71)  43.4  (11.99)  1.177  <0.001 
Female 211 (56.4%)  807 (49.6%)  0.137  0.017 
        
Utilization and Cost        
Primary care visits 11.3 (7.30)  4.6 (4.35)  1.110  <0.001 
Other outpatient visits 18.0 (16.65)  7.2 (10.61)  0.772  <0.001 
Laboratory tests 6.1 (5.27)  2.4 (3.31)  0.844  <0.001 
Radiology tests 3.2 (4.46)  1.3 (2.48)  0.524  <0.001 
Prescriptions filled 40.6 (29.96)  11.9 (17.14)  1.174  <0.001 
Hospitalizations 0.2 (0.52)  0.1 (0.29)  0.403  <0.001 
Emergency department visits 0.4 (1.03)  0.2 (0.50)  0.287  <0.001 
Home-health visits 0.1 (0.88)  0.0 (0.38)  0.108  0.012 
Total costs 8236 (9830)   3047 (5817)  0.643  <0.001 
 
a  A two-tailed t-test for independent samples was used for continuous variables, and a Chi-square test was used for 
dichotomous variables. Continuous variables are reported as mean (standard deviation) and dichotomous variables 
are reported as N (percent). 
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Table 2: All CTA models discriminating between study participants and non-participants 
  
     Smallest  ESS for  ESS for   
Step Strata  Strata N Model (95% CI)   Chance (95% CI)  D (95% CI) 
1 16 6 68.02 (62.93 – 72.83) 1.68 (0.29 – 4.97)   7.52 (5.97 – 9.43) 
2 15 16 67.40 (62.31 – 72.35) 1.64 (0.00 – 4.93)   7.26 (5.73 – 9.07) 
3 11 24 67.30 (62.52 – 71.93) 1.75 (0.22 – 5.16)   5.34 (4.29 – 6.59) 
4 14 29 67.07 (61.80 – 72.03) 1.65 (0.33 – 4.94)   6.87 (5.44 – 8.65) 
5 9 48 66.81 (62.16 – 71.45) 1.71 (0.07 – 5.33)   4.47 (3.60 – 5.48) 
6 8 55 66.14 (61.07 – 70.98) 1.70 (0.05 – 5.21)   3.97 (3.20 – 5.10) 
7 7 84 65.07 (59.89 – 70.08) 1.68 (0.03 – 4.96)   3.76 (2.99 – 4.69) 
8 6 107 63.53 (58.60 – 68.31) 1.90 (0.07 – 5.33)   3.44 (2.78 – 4.24) 
9 4 187 62.25 (57.34 – 66.94) 1.87 (0.23 – 5.36)   2.43 (1.98 – 2.98) 
10 4 222 58.67 (54.39 – 62.84) 1.83 (0.19 – 5.45)   2.82 (2.37 – 3.35) 
11 4 244 58.05 (53.09 – 62.91) 1.82 (0.18 – 5.44)   2.89 (2.36 – 3.53) 
12 2 675 57.84 (52.40 – 63.14) 1.94 (0.30 – 5.23)   1.46 (1.17 – 1.82) 
13 2 823 45.46 (39.77 – 51.18) 1.89 (0.08 – 5.67)   2.40 (1.91 – 3.03) 
14 2 984  6.85 (0.16 – 13.33) 1.92 (0.27 – 5.20) 27.20 (13.0 – 1,248) 
 
Notes: Strata is the number of model endpoints (terminal nodes); smallest strata N is the number of observations in the endpoint with 
the smallest number of observations among all endpoints in the model; ESS is a measure of normed predictive accuracy (0=accuracy 
expected by chance; 100=perfect accuracy); exact 95% confidence intervals for model and chance ESS are computed using 10,000 
bootstrap and Monte Carlo iterations, respectively; and the D statistic indicates the number of additional effects with equivalent ESS 
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needed to obtain a theoretically ideal model with perfect accuracy and maximum possible parsimony for the application [Y&L 2016; 
Y&S, 2016]. 
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Table 3: Absolute standardized differences of baseline covariates, and average standardized difference, for all propensity score 
models.  
 
  Absolute Standardized differences 
Characteristic 
Logistic  
(main effects) 
Logistic  
(saturated) Boosted CTA-2 CTA-4 CTA-6 CTA-9 
Age 0.397 0.603 0.863 0.980 0.626 0.757 0.743 
Female 0.027 0.068 0.148 0.184 0.079 0.133 0.193 
Primary care visits 0.094 0.239 0.501 0.829 0.337 0.364 0.237 
Other outpatient visits 0.126 0.170 0.297 0.659 0.347 0.443 0.424 
Laboratory tests 0.017 0.212 0.389 0.588 0.295 0.129 0.176 
Radiology tests 0.006 0.146 0.207 0.407 0.159 0.194 0.159 
Prescriptions filled 0.154 0.232 0.545 0.301 0.564 0.45 0.171 
Hospitalizations 0.037 0.022 0.113 0.244 0.152 0.211 0.061 
Emergency department visits 0.141 0.139 0.145 0.213 0.147 0.038 0.15 
Home-health visits 0.015 0.025 0.031 0.031 0.024 0.001 0.001 
Total costs 0.039 0.123 0.253 0.417 0.274 0.342 0.190 
Average standardized difference 0.096 0.180 0.317 0.441 0.273 0.278 0.228 
 
Notes: Inverse probability of treatment weights (IPTW) were used with logistic and boosted logistic 
regression models, and stratified weights were used with classification tree analysis (CTA) models.  
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Table 4: Treatment effect estimates using quantile (median) regression as the outcome model. CIs were computed  
using a bootstrap procedure with 2,000 repetitions 
 
Model Participants Non-participants Difference 95% CI P-value 
Naïve 4,819 1,799 3,020 [2758,3282] < 0.0001 
Logistic (main) 3,518 2,346 1,172 [651,1693] < 0.0001 
Logistic (saturated) 2,841 2,103 738 [-126,1602] 0.094 
Boosted 3,480 2,000 1,480 [886,2074] < 0.0001 
CTA-2 3,554 2,018 1,536 [1103,1969] < 0.0001 
CTA-4 3,407 2,042 1,365 [669,2061] < 0.0001 
CTA-6 3,310 2,083 1,227 [685,1769] < 0.0001 
CTA-9 3,084 2,111 973 [430,1516] < 0.0001 
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Table 5: Treatment effect estimates using CTA as the outcome model 
 
Model 
Cutpoint 
Predicting  
Non-participants 
Sensitivity* 
 (Non-participants) 
 Sensitivity*  
(Participants) WESS* 
Naïve 
< 2664 
68.2 82.6 50.8 
LOO 68.2 82.4 50.5 
Logistic (main) 
< 1470 
32.1 96.5 28.5 
LOO 32.0 94.2 26.3 
Boosted 
< 1730 
43.3 92.6 35.9 
LOO 43.3 92.3 35.5 
Logistic (sat) 
< 1470 
35.2 96.8 32.0 
LOO 35.1 91.3 26.4 
CTA-2 
< 2425 
59.0 78.0 37.0 
LOO 59.0 73.4 32.4 
CTA-4 
< 1980 
48.9 88.4 37.3 
LOO 48.9 87.8 36.6 
CTA-6 
< 1740 
42.0 92.3 34.2 
LOO 42.0 87.0 28.9 
CTA-9 
< 1953 
46.6 89.4 36.1 
LOO 46.6 88.0 34.6 
 
Notes: * All estimates are weighted with the exception of the naïve model. WESS is weighted ESS: 0=weighted 
ESS expected by chance, 100=perfect prediction. For every analysis, the first row of data are for the training 
(full sample) analysis, and the second row of data are for the leave-one-out (LOO) one-sample jackknife 
This article is protected by copyright. All rights reserved.
analysis. For all models, observations having costs less than or equal to the tabled threshold value (computed by 
the ODA algorithm) are predicted to be from the non-participant group (coded as 0), and observations having 
costs that are greater than the tabled threshold are predicted to be from the participant group (coded as 1). Exact 
P <0.0001 for all tabled ESS values. The D statistic is not needed to further norm ESS for parsimony, because 
all of the Tabled models had two terminal nodes (endpoints). 
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